Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE229428 |
Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer
|
|
34 | Kornelia Polyak | Aug 15, 2023 | |||
GSE249574 |
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies
|
|
64 | Kornelia Polyak | Apr 24, 2024 | |||
GSE237392 |
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3
|
|
81 | Kornelia Polyak | Apr 24, 2024 | |||
GSE259252 |
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer
|
|
103 |
|
Kornelia Polyak | Oct 14, 2024 | ||
GSE38548 |
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer
|
|
106 | Kornelia Polyak | Jun 09, 2015 | |||
GSE163397 |
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states
|
|
131 | Kornelia Polyak | Nov 02, 2022 | |||
GSE131102 |
Synthetic lethal and resistance interactions with BET bromodomain inhibitors
|
|
210 |
|
Kornelia Polyak | Mar 30, 2020 | ||
GSE104988 |
KDM5B links cellular transcriptome heterogeneity to therapy resistance
|
|
333 |
|
Kornelia Polyak | Oct 03, 2018 | ||
GSE202776 |
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer
|
|
386 |
|
Kornelia Polyak | Nov 09, 2023 |